Emiko Sakaida

28PUBLICATIONS
130CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Sep 02, 2026
Epstein-Barr virus-associated chromatin activation and enhancer engagement in T/NK-cell lymphoproliferative diseases.

|Aug 14, 2026
ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

|Jun 18, 2026
Treatment-free remission and immune profiling after frontline second-generation TKI therapy in CML.

|Jun 11, 2026
Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

|Apr 22, 2026
Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis.

|Nov 28, 2025
Chromatin accessibility in stem cells unveils progressive transcriptional alterations in myelodysplastic syndrome.

Motohiko Oshima, Naoya Takayama, Yaeko Nakajima-Takagi

Pageof 5

Frequent Collaborators

9 joint publications

Yoshiko Atsuta

5 joint publications

Chiaki Nakaseko

5 joint publications

Hitoshi Kiyoi

5 joint publications

Noriyoshi Iriyama